Food Allergy Outcomes Related to White and African American Racial Differences (FORWARD)

与白人和非裔美国人种族差异相关的食物过敏结果(转发)

基本信息

  • 批准号:
    9398764
  • 负责人:
  • 金额:
    $ 84.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-05-11 至 2022-04-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT Background: Food allergy (FA) is a potentially life-threatening condition that affects an estimated 8% of children in the United States. Although differences between African American (AA) and White children in the prevalence and severity of other atopic conditions such as asthma and eczema have been well described, little is known about such differences in FA. The limited existing literature indicates that AA children may have worse clinical outcomes, including rates of FA-related fatal anaphylaxis and FA-related emergency department (ED) visits, than their White peers. Phenotypic and endotypic differences, including rates of sensitization and co-morbidities, between AA and White children are beginning to be examined. Data on racial differences in FA management practices are incomplete; preliminary data suggest that AA families spend significantly less on allergen-free foods and FA medications than do White families. Families caring for children with FA experience significant impairments in psychosocial outcomes, including FA-related quality of life (FAQoL); however, these data come primarily from White, privately insured families, and little is known about psychosocial outcomes in AA families. Two recent reviews concluded that existing studies examining racial disparities in FA are far too methodologically limited to draw definitive conclusions, primarily due to reliance on self-report of FA diagnosis and cross-sectional designs. Specific Aims and Methods: Our goal is to prospectively study a cohort of 600 AA and White children (0-12 years) with FA in order to: 1) Determine variability in clinical FA outcomes between AA and White patients via bimonthly remote assessments, biannual clinic visits, and medical chart review over a two-year period; 2) Examine phenotypic and endotypic differences between AA and White children with FA using specific laboratory specimen collection techniques and assays; 3) Identify differences between AA and White children in FA management practices by parent report (e.g. allergen avoidance and epinephrine carriage); and 4) Determine differences between AA and White children in psychosocial FA-related outcomes (e.g., FA-related quality of life, bullying, anxiety, and worry) via the above survey methods. Hypotheses and Expected Results: We hypothesize that compared to White children, AA children will: have higher rates of food-allergic reactions and FA-related healthcare utilization; demonstrate unique FA phenotypes and endotypes; have poorer knowledge of FA management and worse adherence to preventative behaviors; have limited access to medications and allergen-free foods; and report better quality of life. Significance and Effects on Other Research: Confirming and further characterizing differences between AA and White children with FA will provide the data required to develop clinical guidelines, optimize treatment, and build health policies that meet the needs of both AA and White children.
项目概要/摘要 背景:食物过敏 (FA) 是一种可能危及生命的疾病,影响估计 8% 的人 在美国的孩子们。尽管非裔美国人 (AA) 和白人儿童之间的差异 哮喘和湿疹等其他特应性疾病的患病率和严重程度已得到充分描述,但很少 FA 中的这种差异是众所周知的。有限的现有文献表明 AA 儿童可能有 更糟糕的临床结果,包括与 FA 相关的致命过敏反应和与 FA 相关的急诊科发生率 (ED)访问量高于白人同龄人。表型和内型差异,包括致敏率和 AA 儿童和白人儿童之间的共存疾病正在开始受到检查。 FA 中种族差异的数据 管理规范不完善;初步数据表明,AA 家庭在以下方面的支出显着减少 与白人家庭相比,他们使用不含过敏原的食品和 FA 药物。照顾具有 FA 经验的儿童的家庭 心理社会结果显着受损,包括 FA 相关的生活质量 (FAQoL);然而,这些 数据主要来自白人、私人保险家庭,人们对心理社会结果知之甚少。 AA家庭。最近的两项评论得出的结论是,现有的研究 FA 种族差异的研究太过分了。 方法论上仅限于得出明确的结论,主要是由于 FA 诊断的自我报告的依赖 和横截面设计。 具体目标和方法:我们的目标是前瞻性研究 600 名 AA 和白人儿童(0-12 岁)的队列 年)与 FA 合作,以便: 1)确定 AA 和白人患者之间临床 FA 结果的变异性 通过每两个月一次的远程评估、每两年一次的门诊就诊以及两年内的病历审查; 2) 使用特定的方法检查 AA 和患有 FA 的白人儿童之间的表型和内型差异 实验室标本采集技术和化验; 3)识别AA和White之间的差异 家长报告中儿童的 FA 管理实践(例如避免过敏原和携带肾上腺素); 4) 确定 AA 儿童和白人儿童在 FA 相关社会心理结果方面的差异 (例如,与 FA 相关的生活质量、欺凌、焦虑和担忧)通过上述调查方法进行。 假设和预期结果:我们假设与白人儿童相比,AA 儿童将: 食物过敏反应和 FA 相关医疗保健利用率更高;展示独特的FA 表型和内型;对 FA 管理的了解较差,对预防措施的遵守程度较差 行为;获得药物和无过敏原食品的机会有限;并报告更好的生活质量。 对其他研究的意义和影响:确认并进一步表征差异 AA 和患有 FA 的白人儿童之间的研究将提供制定临床指南所需的数据, 优化治疗并制定满足 AA 和白人儿童需求的健康政策。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ruchi S Gupta其他文献

Ruchi S Gupta的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ruchi S Gupta', 18)}}的其他基金

FORWARD-COVID 19 Supplement
FORWARD-COVID 19 补充资料
  • 批准号:
    10189267
  • 财政年份:
    2020
  • 资助金额:
    $ 84.84万
  • 项目类别:
Intervention to Reduce Early (Peanut) Allergy in Children (iREACH)
减少儿童早期(花生)过敏的干预措施 (iREACH)
  • 批准号:
    10212208
  • 财政年份:
    2019
  • 资助金额:
    $ 84.84万
  • 项目类别:
Intervention to Reduce Early (Peanut) Allergy in Children (iREACH)
减少儿童早期(花生)过敏的干预措施 (iREACH)
  • 批准号:
    10425291
  • 财政年份:
    2019
  • 资助金额:
    $ 84.84万
  • 项目类别:
Intervention to Reduce Early (Peanut) Allergy in Children (iREACH)
减少儿童早期(花生)过敏的干预措施 (iREACH)
  • 批准号:
    10666514
  • 财政年份:
    2019
  • 资助金额:
    $ 84.84万
  • 项目类别:
Intervention to Reduce Early (Peanut) Allergy in Children (iREACH)
减少儿童早期(花生)过敏的干预措施 (iREACH)
  • 批准号:
    9982763
  • 财政年份:
    2019
  • 资助金额:
    $ 84.84万
  • 项目类别:
Food Allergy Management and Outcomes Related to Racial/Ethnic Differences from Infancy through Adolescence: The FORWARD Study
食物过敏管理和与从婴儿期到青春期的种族/民族差异相关的结果:FORWARD 研究
  • 批准号:
    10446840
  • 财政年份:
    2017
  • 资助金额:
    $ 84.84万
  • 项目类别:
Food Allergy Management and Outcomes Related to Racial/Ethnic Differences from Infancy through Adolescence: The FORWARD Study
食物过敏管理和与从婴儿期到青春期的种族/民族差异相关的结果:FORWARD 研究
  • 批准号:
    10580069
  • 财政年份:
    2017
  • 资助金额:
    $ 84.84万
  • 项目类别:
Food Allergy Outcomes Related to White and African American Racial Differences (FORWARD)
与白人和非裔美国人种族差异相关的食物过敏结果(转发)
  • 批准号:
    9922208
  • 财政年份:
    2017
  • 资助金额:
    $ 84.84万
  • 项目类别:
FORWARD Supplement: Common Data Elements for Food Allergy
FORWARD 补充:食物过敏的通用数据元素
  • 批准号:
    10868981
  • 财政年份:
    2017
  • 资助金额:
    $ 84.84万
  • 项目类别:
Improving Food Allergy Management through an Electronic Physician Support Tool
通过电子医生支持工具改善食物过敏管理
  • 批准号:
    8584033
  • 财政年份:
    2013
  • 资助金额:
    $ 84.84万
  • 项目类别:

相似海外基金

I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 84.84万
  • 项目类别:
    Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 84.84万
  • 项目类别:
    Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 84.84万
  • 项目类别:
    Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 84.84万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 84.84万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 84.84万
  • 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 84.84万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 84.84万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 84.84万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 84.84万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了